severe aplastic anemia
Showing 1 - 25 of 53
Severe Aplastic Anemia Trial (Busulfan, Flu/Cy/ATG or Cy/ATG)
Not yet recruiting
- Severe Aplastic Anemia
- Busulfan
- Flu/Cy/ATG or Cy/ATG
- (no location specified)
Oct 1, 2023
Severe Aplastic Anemia Trial in Hefei (Anti-Thymocyte Globulin (Rabbit))
Recruiting
- Severe Aplastic Anemia
- Anti-Thymocyte Globulin (Rabbit)
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of University of Science and Techn
Sep 9, 2023
Severe Aplastic Anemia, Single Lineage Cytopenias, T-LGL, Hypoplastic MDS Trial run by the National Heart, Lung, and Blood
Not yet recruiting
- Severe Aplastic Anemia
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 23, 2023
Severe Aplastic Anemia Trial in Tianjin (Cyclophosphamide added to standard immunosuppressive therapy with eltrombopag)
Recruiting
- Severe Aplastic Anemia
- Cyclophosphamide added to standard immunosuppressive therapy with eltrombopag
-
Tianjin, Tianjin, ChinaRegenerative Medicine Center
Jul 27, 2023
Severe Aplastic Anemia Trial in Tianjin (avatrombopag)
Recruiting
- Severe Aplastic Anemia
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Feb 7, 2023
Severe Aplastic Anemia Trial run by the NHLBI (Eltrombopag, Cyclosporine, Horse-Anti-thymocyte-Globulin)
Recruiting
- Severe Aplastic Anemia
- Eltrombopag
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Severe Aplastic Anemia Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Sirolimus)
Recruiting
- Severe Aplastic Anemia
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Severe Aplastic Anemia, MDS (Myelodysplastic Syndrome) Trial in Baltimore, Bethesda, Minneapolis (Miltenyi CD34 Reagent System,
Recruiting
- Severe Aplastic Anemia
- MDS (Myelodysplastic Syndrome)
- Miltenyi CD34 Reagent System
- Donor derived G-CSF mobilized PBC
-
Baltimore, Maryland
- +2 more
Jan 25, 2023
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +36 more
- Cyclophosphamide
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 23, 2023
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)
Not yet recruiting
- Acute Lymphoblastic Leukemia in Remission
- +10 more
- CliniMACS
-
Houston, Texas
- +1 more
Dec 8, 2022
Fanconi Anemia, Severe Aplastic Anemia, MDS Trial in Minneapolis (Total Body Irradiation (TBI) (Plan 1), Cyclophosphamide (CY)
Recruiting
- Fanconi Anemia
- +2 more
- Total Body Irradiation (TBI) (Plan 1)
- +8 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Nov 2, 2022
Mucopolysaccharidosis I, Mucopolysaccharidosis VI, Adrenoleukodystrophy Trial in Denver, Valhalla, Salt Lake City (Human
Completed
- Mucopolysaccharidosis I
- +15 more
- Human Placental Derived Stem Cell
-
Denver, Colorado
- +2 more
Oct 24, 2022
Hemoglobinopathy (Disorder), Severe Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Saint Petersburg (Haploidentical
Recruiting
- Hemoglobinopathy (Disorder)
- +2 more
- Haploidentical Hematopoietic Cell Transplantation
-
Saint Petersburg, FloridaJohns Hopkins All Children's Hospital
Sep 13, 2022
Severe Aplastic Anemia Trial in United States (drug, radiation, procedure)
Completed
- Severe Aplastic Anemia
- Antithymocyte Globulin (ATG)
- +7 more
-
Duarte, California
- +27 more
Jul 21, 2022
Acquired and Inherited Bone Marrow Failure Syndromes
Recruiting
- Severe Aplastic Anemia
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 12, 2022
Severe Aplastic Anemia Trial in Tianjin (Hetrombopag Olamine+Standard Therapy, Placebo+Standard Therapy)
Recruiting
- Severe Aplastic Anemia
- Hetrombopag Olamine+Standard Therapy
- Placebo+Standard Therapy
-
Tianjin, Tianjin, ChinaBlood Diseases Hospital, Chinese Academy of Medical Sciences
Jul 28, 2022
Severe Aplastic Anemia Trial in Worldwide (eltrombopag, Cyclosporine)
Completed
- Severe Aplastic Anemia
-
Ribeirao Preto, SP, Brazil
- +19 more
Jun 29, 2022
Severe Aplastic Anemia Trial in Tianjin (Avatrombopag)
Recruiting
- Severe Aplastic Anemia
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital, Chinese Acade
Jun 22, 2022
Idiopathic Aplastic Anemia, Severe Aplastic Anemia, Moderate Aplastic Anemia Requiring Transfusions Trial (HSCT Arm group)
Not yet recruiting
- Idiopathic Aplastic Anemia
- +2 more
- HSCT Arm group
- (no location specified)
Jun 10, 2022
Severe Aplastic Anemia Who Relapsed After Immunosuppressive
Active, not recruiting
- Severe Aplastic Anemia
-
Bethesda, MarylandNational Heart, Lung and Blood Institute (NHLBI)
Apr 7, 2022
Severe Aplastic Anemia Who Developed High Risk Clonal Evolution
Completed
- Severe Aplastic Anemia
-
Bethesda, MarylandNational Heart, Lung and Blood Institute (NHLBI)
Apr 7, 2022
Severe Aplastic Anemia Trial run by the NHLBI (Cohort 1: hATG, CsA, EPAG Day 14 to Month 6, Cohort 2: hATG, CsA, EPAG Day 14 to
Recruiting
- Severe Aplastic Anemia
- Cohort 1: hATG, CsA, EPAG Day 14 to Month 6
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 5, 2022
Severe Aplastic Anemia, Bone Marrow Failure Syndromes Trial in Baltimore, Milwaukee (procedure, drug, radiation)
Completed
- Severe Aplastic Anemia
- Bone Marrow Failure Syndromes
- Bone marrow transplant
- +7 more
-
Baltimore, Maryland
- +1 more
Feb 10, 2022